Deal Library / Pharma BD Deal Intelligence

Hospira Inc. — Pharma Deals

The Pharma Closeout tracks 5 deals, $1.1B in disclosed deal value, 5 with a post-close Outcome Score for Hospira Inc..

Median Critic Score: 83  ·  Median Outcome Score: 23

Best outcome: Hospira Inc. / Abbott Hospital Products Division (54)  ·  Weakest outcome: Hospira Inc. / Orchid Chemicals & Pharmaceuticals Ltd. (API and R&D facilities) (22)

All 5 deals

• Hospira Inc. / Abbott Hospital Products Division — 2004 · Mixed — partial payoff, real shortfalls.
• Hospira Inc. / Javelin Pharmaceuticals, Inc. — 2010 · $145M · Did not work — the deal failed to deliver.
• Hospira Inc. / Orchid Chemicals & Pharmaceuticals (Generic Injectables Business) — 2010 · $400M · Did not work — the deal failed to deliver.
• Hospira Inc. / Orchid Chemicals & Pharmaceuticals Ltd. (API and R&D facilities) — 2012 · $200M · Did not work — the deal failed to deliver.
• Hospira Inc. / Orchid Chemicals & Pharmaceuticals Ltd. (Generic Injectables business) — 2009 · $400M · Did not work — the deal failed to deliver.

← Deal Library  ·  Interactive search  ·  How we score deals